The Children's Oncology Group's 2013 five year blueprint for research
- 19 December 2012
- journal article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 60 (6) , 955-956
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Challenges and opportunities in childhood cancer drug developmentNature Reviews Cancer, 2012
- A decade’s perspective on DNA sequencing technologyNature, 2011
- Phase III Clinical Trial Development: A Process of Chutes and LaddersClinical Cancer Research, 2010
- US cancer trials may go the way of the OldsmobileNature Medicine, 2010
- Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First CenturyJournal of Clinical Oncology, 2010
- Progress in Childhood Cancer: 50 Years of Research Collaboration, a Report From the Children's Oncology GroupSeminars in Oncology, 2008
- Chronic Health Conditions in Adult Survivors of Childhood CancerNew England Journal of Medicine, 2006
- Long‐term follow‐up of childhood cancer survivors: Future directions for clinical care and researchPediatric Blood & Cancer, 2005
- New Approaches to Drug Development in Pediatric OncologyThe Cancer Journal, 2005
- Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)New England Journal of Medicine, 1948